Evidence map›Paper›PMID 25328863›Full record

ArticleThe lancet. Psychiatry2014

Progesterone Reduces Cocaine Use in Postpartum Women with a Cocaine Use Disorder: A Randomized,Double-Blind Study.

Kimberly Ann Yonkers, Ariadna Forray, Charla Nich, Kathleen M Carroll, Cristine Hine, Brian C Merry, Howard Shaw, Julia Shaw, Mehmet Sofuoglu

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in The lancet. Psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05128071 (PRevention Of Methamphetamine Use Among Postpartum Women Trial), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05128071 early_phase1completednot on this mapstarted 2022, after this paper: background citation

PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)

TypeinterventionalSponsorUniversity of UtahRan2022 to 2024Enrolled34ConditionsMethamphetamine-dependence, Postpartum AbstinenceArmsProgesterone, Placebo
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2016
    Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kimberly Ann YonkersDepartments of Psychiatry, Obstetrics and Gynecology and School of Epidemiology and Public Health, Yale University School of Medicine,40 Temple Street, Suite 6B, New Haven, Connecticut, USA 06510.
Ariadna ForrayDepartment of Psychiatry, Yale University School of Medicine,40 Temple Street, Suite 6B, New Haven, Connecticut, USA 06510.
Charla NichDepartment of Psychiatry, Yale University School of Medicine, VA CT Healthcare System, 950 Campbell Avenue, West Haven, CT 06516.
Kathleen M CarrollDepartment of Psychiatry, Yale University School of Medicine, VA CT Healthcare System, 950 Campbell Avenue, West Haven, CT 06516.
Cristine HineDepartment of Psychiatry, Yale University School of Medicine,40 Temple Street, Suite 6B New Haven, Connecticut, USA 06510.
Brian C MerryDepartment of Psychiatry, Yale University School of Medicine,40 Temple Street, Suite 6B, New Haven, Connecticut, USA 06510.
Howard ShawDepartment of Obstetrics and Gynecology, Yale New Haven Hospital, 1450 Chapel Street, New Haven, CT 06511.
Julia ShawDepartment of Obstetrics and Gynecology, Yale University School of Medicine, 20 York St, New Haven, CT 06511.
Mehmet SofuogluDepartment of Psychiatry, Yale University School of Medicine, VA CT Healthcare System, 950 Campbell Avenue, West Haven, CT 06516.
Yale University · USVA Connecticut Healthcare System · USYale New Haven Hospital · US

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI KOBER, HEDY · 1994 to 2018
$40.5M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Project START: Screening to Augment Referral to TreatmentR01DA027194 · NIDA · YALE UNIVERSITY · PI MARTINO, STEVE, YONKERS, KIMBERLY A · 2010 to 2014
$3.3M
Progesterone for Postpartum Cocaine RelapseR21DA029914 · NIDA · YALE UNIVERSITY · PI SOFUOGLU, MEHMET, YONKERS, KIMBERLY A · 2010 to 2011
$448k
NCATS NIH HHS UL1 TR000142NIDA NIH HHS K12 DA000167NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA027194NIDA NIH HHS R21 DA029914
6 · The paper itself

Abstract

backgroundProgesterone modulates multiple brain functions implicated in the pathogenesis ofdrug addiction. During high endogenous progesterone states, women reduce use of cocaine. We sought to test whether progesterone replacement reduces cocaine use in postpartum women with a cocaine use disorder (CUD).

methodsA 12-week, double-blind, parallel, randomized, placebo-controlled pilot trial with a 3-month post trial follow-up. 25 women within 12 weeks of deliverywere randomized to placeboand 25 to100 mgs of oral micronized progesterone, administered twice daily. Participants were recruited from obstetrical clinics. Randomization and allocation were performed by the study biostatistician. Attrition was 18% and the analysis included all50participants. Outcomes were self-reported days of cocaine use and positive urine toxicology assays for cocaine metabolites.

findingsParticipants randomized to placebo compared to progesterone had increased likelihood of cocaine use per week (RR=1·19; 95% confidence interval (CI)=1·05 to 1·36; p<0·01). At the three-month post trial visit the difference between groups was not significant (Likelihood RatioΧ

interpretationThese preliminary findings support the promise of progesterone treatment in postpartum women with a CUD and could constitute a therapeutic break through.

fundingUS National Institute on Drug Abuse; Veterans Administration.

Indexed as

Cocaine AbuseCocaine DependenceCocaine Use DisorderObstetrics and GynecologyPostpartumProgesteroneWomen

Identifiers

PMID25328863
PMCPMC4199242
OpenAlexW2131926427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.